Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00284830 · ClinicalTrials.gov registry record · NA
SAVEPACe - Search AV Extension and Managed Ventricular Pacing for Promoting Atrio-Ventricular Conduction
A NA study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- NA
- Development phase
- 1,070
- Enrollment target
NCT00284830 is a NA study that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 1,070 participants.
The verdict
NCT00284830, a NA study, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,070 participants
- Enrollment target
Study Summary
SAVE PACe is a large, prospective, single-blinded, randomized clinical trial with the main objective to study the effect of unnecessary right ventricular apical pacing on the clinical outcome of time to development of persistent AF.
Interventions
- DEVICE Implantable Pulse Generators
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,070 participants |
| Start Date | 2003-01 |
| Est. Completion | 2008-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00284830
The ClinicalTrials.gov registry entry for NCT00284830 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,070 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Implantable Pulse Generators is the first listed.
NCT00284830 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00284830 about?
NCT00284830 is a clinical study titled "SAVEPACe - Search AV Extension and Managed Ventricular Pacing for Promoting Atrio-Ventricular Conduction". SAVE PACe is a large, prospective, single-blinded, randomized clinical trial with the main objective to study the effect of unnecessary right ventricular apical pacing on the clinical outcome of time to development of persistent AF.
What is the current status of trial NCT00284830?
This trial is currently completed. It is a NA study. The enrollment target is 1,070 participants. The study started on 2003-01. Estimated completion is 2008-02.
What interventions are being tested in trial NCT00284830?
The interventions under investigation include: Implantable Pulse Generators (DEVICE).
Who is sponsoring clinical trial NCT00284830?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.